Feedback / Questions
BI 765049 - Boehringer Ingelheim
ezabenlimab (BI 754091) - Boehringer Ingelheim
http://clinicaltrials.gov/ct2/show/NCT06091930
Dec 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next